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ABSTRACT: This study addressed whether whole cell pertussis-vaccinated children
have a different risk of atopic disorders compared with children who did not receive this
vaccination.
Data on vaccination status, atopic disorders and child and family characteristics of
the children of 700 families were collected in this retrospective study. A minority of
these 700 families refused vaccinations for religious reasons. The relation between
pertussis-vaccination status and atopic disorders was analysed by means of adjusted
logistic regression for repeated measurements in order to account for the correlation
between sibship members.
The 700 families included 1,961 children. Data on vaccination status and atopic
disorders were available for 1,724 children. Vaccinated children had a reduced risk of
atopic disorders.
Whole cell pertussis vaccination is associated with a lower risk of atopic disorders,
though other vaccine components (diphtheria, tetanus, poliomyelitis) or other vaccina-
tions may also be involved.
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An increased risk of atopic disorders in pertussis or
diphtheria tetanus pertussis (DTP) vaccinated children has
been reported [1–4], but this was not confirmed by more
recent observational studies [5–7], a randomised placebo-
controlled trial [8], and an ecological study [9]. Reports of
adverse effects of vaccinations usually cause controversy and
debate between advocates and opponents of vaccination
programmes. The current study evaluated the role of the
pertussis vaccination as a risk factor for atopic disorders
within a study of family size and birth order as risk factors for




In a study in the Netherlands designed to determine the role
of sibship size and birth order as risk factors for asthma,
allergy and eczema 700 families with index children born in
1988, 1989 or 1990 were sampled from files administered by
the Municipal Health Service covering the municipality of
Zwijndrecht, a town withw40,000 inhabitants. A subgroup of
these families adhere to the orthodox reformed religion and
their children mostly attend orthodox reformed schools.
Some of the parents of this group refrain from vaccinations
for religious reasons. According to an official schedule in the
Netherlands, children receive four vaccinations of DTP
(whole cell), Poliomyelitis and Haemophilus influenzae type
B at agedv1 yr (before 1998 at aged 3, 4, 5 and 11 months),
mumps-measles-rubella (MMR) at aged 14 months, a booster
of DT-Poliomyelitis at aged 4 and 9 yrs and a booster of
MMR at aged 9 yrs. Since 2002 a booster of acellular
pertussis is administered at aged 4 yrs.
Study design
This was a retrospective study using datafiles from routine
health checkups from birth till adolescence.
Methods
Data on preventive health checkups of index children aged
6 yrs performed by the Municipal Health Service were
collected from the files. Data from files of their siblings
were also extracted. The following data were used: presence
and type of allergy, asthma, eczema, current medication, birth
order, sibship size, date of birth, sex, date of checkup, year of
birth of the mother, postal code, country of birth of the
parents, occupation of the breadwinner, atopic disorders of
the parents, vaccination status, and duration of breastfeeding.
A child was considered having asthma, allergy or eczema if
this was mentioned in the file by the physician who did the
checkup, in the questionnaire filled out by the parents or in a
letter from a paediatrician/pulmonologist.
Analysis
The independent relation of pertussis-vaccination status
with allergy, eczema, asthma and any atopic disorder (allergy,
eczema or asthma) was evaluated within families by means of
logistic regression for repeated measurements (Generalized
Estimating Equations) [10], families being the units of
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analysis, which takes correlation between family members
into account. Analyses were performed both in univariate and
multivariate models with adjustments for the subset of the
following variables, which changed the univariate point
estimate by at least 10% [11]: sibship size, birth order, year
of birth, season of birth, sex, breast feeding forw1 month (yes/
no), age at the time of checkup, allergy or asthma of the
parents, level of occupation of the bread-winner (five levels),
age of the mother at the time of delivery, level of urbanisation
(two levels) and country of origin (both parents born in the
Netherlands yes/no). A two-sided p-value of 0.05 was con-
sidered significant.
Results
The 700 families comprised 1,961 children. Both vaccina-
tion status and atopic status was available for 1,724 children;
of these 44 (2.6%) were not vaccinated for pertussis, mostly
for religious reasons. Of these, 39 had received no vaccina-
tions at all, four received only the polio-vaccination, and one
received DT-polio (without pertussis). The 1,724 children had
their health checkup at a mean age of 5.9 yrs (SD: 0.6 yrs).
The types of allergy mentioned were house-dust mite, pollen,
furry pets, food allergy, hay fever and allergic rhinitis. The
prevalence of atopic disorders in both groups is shown in
table 1. Crude odds ratios (OR)s for atopic disorders
(vaccinated/unvaccinated) varied between 0.33–0.69. Adjusted
ORs ranged 0.23–0.40, consistent with a substantially reduced
risk of atopy in pertussis-vaccinated children. The same
analysis in the subgroup of children attending orthodox
reformed schools (39 unvaccinated and 128 vaccinated child-
ren) yielded similar point estimates. For "any atopic disorder"
the adjusted OR (vaccinated/unvaccinated) in this subgroup
was 0.16 (95% confidence interval 0.04–0.67, data not shown
in table).
Discussion
In the present study, pertussis-vaccinated children were at a
considerably lower risk of atopic disorders than unvaccinated
children. Most vaccinated children received the combined
DTP-polio vaccine. Hence, the comparison of children with
and without pertussis vaccination was almost equivalent to
the comparison of DTP-polio vaccination and no vaccination
at all. Data used for this study were not collected to answer
the present research question, and consequently no sample
sizes for vaccinated and unvaccinated groups were computed.
A total of 44 unvaccinated children were found and the
relations studied were significant. Adjustment for confoun-
ders could have been a problem with so few children at risk,
with resulting empty cells and huge confidence intervals.
However, this was not the case and the results of the adjusted
analyses showed similar relations. All data were collected
retrospectively from files and possibly misreporting, most
likely underreporting, of atopic diseases may have occurred.
It could be that this misclassification is differential, i.e. related
to the risk factor under study. This may mean that parents of
vaccinated children report less atopy than unvaccinated
children. However, the relations found persisted and even
became somewhat stronger when the analyses were restricted
to the more homogenous group of children attending orthodox
reformed schools. Even if within this more homogenous
group underreporting would be differential, it would be more
likely that parents of unvaccinated children (more orthodox
religious families) would report less than parents of vacci-
nated children. However, this bias would lead to an attenua-
tion of the OR and the unbiased OR would even be more
extreme.
In the Netherlands pertussis is endemic in childhood and
shows 4-yearly peaks [12]. The highest incidence is reported
in infants aged v1 yr (35 per 100,000 per year during
1989–1993). Pertussis cases are reported both in vaccinated
and unvaccinated children, the incidence in the latter group
being roughly 10-fold the incidence in the vaccinated group.
The relatively low incidence in the unvaccinated group
(compared to completely unvaccinated groups in Germany)
can be explained by herd immunity.
As only 0.7% of the study population was born after 1997,
the role of acellular pertussis vaccine is negligible in this study.
Given the hygiene hypothesis, it would be expected that the
immune system of the unvaccinated children would have
shifted more towards the T-helper cell 1-side, inconsistent
with a raised risk of atopy. On the other hand, the immune
system of vaccinated children is triggered with the (albeit
killed) microorganisms at a very young age and from this
point of view the findings of the current study fit in the
hygiene hypothesis and are biologically plausible.
The findings of the current study are consistent with a
recent study in Germany by GRU¨BER et al. [7]. Several studies
found an increased risk of asthma and allergy in DTP or
pertussis-vaccinated children [1–4], but this may be due to
residual confounding or confounding by indication as the
reasons for not vaccinating are not described and may be
related to the outcome. A number of studies found no relation
between the DTP or the pertussis-vaccination and atopy [5–9].
One of these is a randomised controlled trial [8], which
compared three groups that received different cocktails of
DTP with a control group that received DT only. However
the age of evaluation at 2.5 yrs was rather young and this may
account for the lack of an effect. HENDERSON et al. [5] found
no difference, but in this study the outcome was wheezing at
the age of not more than 42 months. All (but one) studies
mentioned above are observational and residual confounding
cannot be excluded, especially when the reason for refraining
from vaccination is not known. It is important for future
studies to include groups that are as homogenous as possible
and adequately describe the differences between vaccinated
and unvaccinated groups.
Conclusion
The results from this study suggest that whole cell pertussis-
vaccinated children have a lower risk of atopic disorders.
Table 1. – Prevalence of atopic disorders among unvaccinated
and vaccinated children and crude and adjusted odds ratios
(OR)s for atopic disorders (vaccinated/unvaccinated) with
95% confidence intervals (95% CI) for adjusted ORs.
Allergy Eczema Asthma Any atopic
disorder
Unvaccinated % 11.4 13.6 11.4 22.7
Vaccinated % 5.2 4.9 8.7 13.8
Crude OR 0.40 0.33 0.69 0.51
Adjusted OR# 0.23 0.26 0.40 0.37
95% CI 0.07–0.79 0.11–0.63 0.10–1.70 0.16–0.87
#: Variables included in the multivariate model were for allergy (birth
order, family size, year of birth, atopy of the father, age of mother at
birth), eczema (birth order, atopy of the father, age of mother at birth),
asthma (birth order, family size, year of birth, atopy of the father, age of
mother at birth) and any atopy (birth order, family size, atopy of the
father, age of mother at birth). n=44 (unvaccinated) and 1,680
(vaccinated).
963ATOPY IN PERTUSSIS-VACCINATED CHILDREN
However, other vaccine components (diphtheria, tetanus,
poliomyelitis) or other vaccinations may also play a role.
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